Gilead Sciences, Inc.
WebAccess and Health Equity. Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Gilead Sciences - Wikipedia
WebGilead Sciences, Inc. (/ ˈ ɡ ɪ l i ə d /) is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
About Us | Gilead
WebAbout Us. At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine.
Gilead Sciences - Wikipedia, la enciclopedia libre
WebGilead Sciences es una compañía biotecnológica estadounidense dedicada a investigar, descubrir, desarrollar y comercializar fármacos para tratar enfermedades. Desde su fundación en 1987 y durante muchos años la compañía se dedicó principalmente a desarrollar medicamentos antivirales para tratar pacientes infectados con VIH, hepatitis …
Gilead Sciences
Web18 Marzo 2024. Gilead celebra el I Encuentro INVIHFORUM para el manejo de las comorbilidades neuropsiquiátricas y la mejora de la salud a largo plazo, grandes retos para garantizar un envejecimiento saludable en las personas con VIH. 14 Febrero 2024. AAEH y Gilead entregan la 6ª edición de becas a proyectos de microeliminación en hepatitis ...
Virology, Oncology and Inflammation Pipeline | Gilead
WebUpdated: April 25, 2024, data as of end of Q1. We have the strongest and most diversified pipeline in our history and are on track to achieve our ambition, set in 2019, of delivering 10+ transformative therapies by 2030. 54 Total programs. 17Phase 1 21Phase 2 …
Gilead Nordics: Oncology, HIV and Virology
WebGilead is a research-based biopharmaceutical company driven by our vision of creating a healthier world for all people. Gilead Nordics includes Sweden, Finland, Norway, Denmark, and Iceland.
Medicines | Gilead
WebGilead is committed to helping improve the lives of people around the world by bringing forward medicines that prevent, treat and cure devastating diseases. We currently offer more than 25 therapies in the United States and are rapidly growing our portfolio through internal research and development, as well as collaborations with academic and ...
Press Releases | Gilead
Webden 25. apr. 2024 · Gilead Sciences to Release Fourth Quarter & Full Year 2023 Financial Results on Tuesday, February 6, 2024. January 22, 2024. Gilead Provides Update on Phase 3 EVOKE-01 Study. Read the latest news about Gilead's work in COVID-19, HIV, viral hepatitis, cancer and other areas.
Nuestras Áreas Terapéuticas - Gilead
WebNuestras Áreas Terapéuticas. En Gilead estamos comprometidos con el avance y mejora de la atención a los pacientes de todo el mundo, desarrollando medicamentos en áreas con necesidades médicas no cubiertas en los campos de …